Looking at top Wall Street opinions, UnitedHealth Group Incorporated (NYSE: UNH) has recently made its way into the research list of Citigroup – signaling that their analyst’s rating adjustment is noteworthy. This stock was upgraded to a rating of Buy in the eyes of Citigroup, whereas its previous rating was Neutral in the eyes of Citigroup, as reported on Friday, May 10th, 2019. Another heavy-hitting research note was published by UBS on Tuesday April 23rd, 2019, with this firm Initiated UNH to an updated rating of Neutral. In the past six months and three months of trading, shares of UnitedHealth Group Incorporated (UNH) have moved by -13.07% and -10.76%, respectively.
Brokerage Updates Related to UnitedHealth Group Incorporated (UNH) Stock
This publicly-traded organization generated losses of -0.50% over the last 5 sessions. Right now, this stock is the subject of 26 analysts’ evaluations, who – on average – have given this company’s shares a Strong Buy rating. Not a Single analyst have given underperform rating or sell rating, and 12 have given a rating of Buy or better. Based on the 26 stock market experts following this company, the average 12-month price target is $288.04. Moreover, individual price targets range between $235.00-$345.00. With its recent move to $285.00, we can see that these firms project this stock will loss by -1.13% in one year.
Updates from UnitedHealth Group Incorporated (UNH) SEC Form 4
This particular company’s shares have garnered a lot of attention in recent days, as insiders are unloading their holdings while having generated a 0.40% rise since the beginning of the calendar year. A Director at UnitedHealth Group Incorporated (UNH) sold off some of its shares in a transaction that was finalized on May 06. WICHMANN DAVID S bought 20,000 shares of the organization’s stock at $231.79 apiece and racked up $4,635,730 in earnings from the purchase. Now, WICHMANN DAVID S holds 904,367 shares of the company following the exchange. A Director of the organization named MCNABB FREDERICK WILLIAM III, was engaged in a transaction that occurred on May 01 that managed to be worth $1,499,534 from the purchase of 6,430 common shares at a price of $233.21 per individual share.
UnitedHealth Group Incorporated (NYSE:UNH) Results in the Pipeline
The next scheduled release of financial results for UnitedHealth Group Incorporated will be for the Mar-19 quarter. As it stands right now, market analysts are anticipating the per-share earnings for the three-month period will be $3.60. In the same vein, they expect sales for the quarter to amount to $59,709.20 million.
Now let’s turn to earnings surprise history: in the most recent quarter, the company reported about $60,308.00 million in revenue alongside EPS at $3.73. On average, the analyst projection was calling for $58,417.00 million with $3.28 per share in earnings, respectively. In the preceding quarter, this company’s revenue reached $56,556.00 million, with earnings per share ending up at $3.41.
Enterprise Products Partners L.P. (NYSE:EPD) experienced a gain of 0.77% from the closing price in the previous trading day. That boost the price to $28.91 per share, as observed on December 31st, 1969, at a time when the total trading volume reached 3,221,891 shares of stock – compared to the typical average of 3.44M shares per day (as recorded over the past three months). The consensus estimate for these shares has been shifted to $34.00.
Pricing Indications for Enterprise Products Partners L.P. (EPD)
This organization has had a price-to-earnings ratio of 14.04 in the last year. Meanwhile, it gained 28.92 from its observable 50-day simple moving average. Right at this moment, the per-share value is 3.26% higher than the mean per-share price over the last 200 days in the market.
Enterprise Products Partners L.P. (NYSE:EPD) In-Depth Brokerage Insights
We can see that a number of brokerage firms are putting their focus onto this stock. Out of this group, 0 have a sell rating, 13 have a Buy rating, 11 have an outperform rating, while 0 provided a Hold rating for these shares – thanks to data from Thomson Reuters I/B/E/S. Additionally, 0 have recommended that these shares are an Underperforming investment. The current consensus recommendation is at 1.50 , based on information from Thomson Reuters.
EPD Stock Value Potential
In trading activity as of late, this stock’s value was 28.00 up from its 200 day moving average, while also 0.05% up when compared against its 50-day simple moving average. Over the course of the past year of trading, the share price stuck in the range of $31.00-$39.00. The market value for the entire organization reached 62.22B. In the last trading session, the price ended the day at $28.69. The institutional holdings related to this organization account for 0.30%, and the Beta factor is now 0.92. This company’s RSI (Relative Strength Index) managed to hit 51.76.
Enterprise Products Partners L.P. (NYSE:EPD) Analyst Points of Focus
Enterprise Products Partners L.P. (EPD) has found itself inside of Goldman’s research list, so their analyst rating adjustment is worth taking note of. This stock was upgraded to Buy, compared to its previous rating of Neutral by Goldman, as garnered from a news report on Wednesday April 3rd, 2019. An additional helpful research note was sent out by Credit Suisse’s on Thursday October 11th, 2018. The brokerage decided to initiated EPD to Outperform.